NASDAQ:HSIC - Henry Schein Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$85.67 -0.21 (-0.24 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$85.88
Today's Range$85.21 - $86.60
52-Week Range$62.56 - $86.60
Volume1.61 million shs
Average Volume1.58 million shs
Market Capitalization$12.93 billion
P/E Ratio23.97
Dividend YieldN/A
Beta0.98
Henry Schein logoHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNASDAQ:HSIC
CUSIP80640710
Phone631-843-5500

Debt

Debt-to-Equity Ratio0.34
Current Ratio1.29
Quick Ratio0.68

Price-To-Earnings

Trailing P/E Ratio23.97
Forward P/E Ratio20.79
P/E Growth2.44

Sales & Book Value

Annual Sales$12.46 billion
Price / Sales1.05
Cash Flow$4.9292 per share
Price / Cash17.38
Book Value$18.00 per share
Price / Book4.76

Profitability

EPS (Most Recent Fiscal Year)$3.60
Net Income$406.29 million
Net Margins3.15%
Return on Equity20.40%
Return on Assets7.68%

Miscellaneous

Employees22,000
Outstanding Shares153,110,000
Market Cap$12.93 billion

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Henry Schein shares split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its board has approved a share repurchase plan on Tuesday, September 19th 2017, which permits the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 6.3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board believes its stock is undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) announced its earnings results on Monday, August, 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.03. The business had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.88 EPS. View Henry Schein's Earnings History.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for Henry Schein.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY18 earnings guidance on Monday, August, 6th. The company provided earnings per share (EPS) guidance of $4.06-4.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.11.

What price target have analysts set for HSIC?

18 Wall Street analysts have issued 12 month price objectives for Henry Schein's stock. Their predictions range from $73.00 to $102.00. On average, they anticipate Henry Schein's stock price to reach $84.00 in the next twelve months. This suggests that the stock has a possible downside of 1.9%. View Analyst Price Targets for Henry Schein.

What is the consensus analysts' recommendation for Henry Schein?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Henry Schein.

What are Wall Street analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:
  • 1. Barrington Research analysts commented, "We are currently modeling $4.10. It is important to note that management’s adjusted EPS guidance does not include any impact from the upcoming animal health spin-off and merger, which is expected to occur before year end. In addition, the guidance does not factor in any future M&A activity." (8/7/2018)
  • 2. According to Zacks Investment Research, "Post a better-than-expected first quarter performance on overall segmental growth, we are impressed with Henry Schein's strong share gains in the North American and overseas markets. Despite the better-than-expected revenue performance in the last-reported quarter, we are disappointed with the year-over-year deterioration in Henry Schein's gross and operating margin due to higher costs and expenses. We currently await the completion of the company’s global Animal Health business' planned spin-off. This business contributes nearly 30% to the company’s topline. The spin off is expected to bring in major changes to Henry Schein’s overall operating results. On the flip side, pricing pressure and tough competition are major woes. Overall, in the past six months, Henry Schein has outperformed its industry." (8/2/2018)

Are investors shorting Henry Schein?

Henry Schein saw a drop in short interest in the month of August. As of August 31st, there was short interest totalling 17,291,234 shares, a drop of 8.4% from the August 15th total of 18,867,236 shares. Based on an average daily volume of 1,138,855 shares, the days-to-cover ratio is presently 15.2 days. Currently, 11.5% of the company's shares are short sold. View Henry Schein's Current Options Chain.

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:
  • Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 68)
  • Mr. James P. Breslawski, Vice Chairman & Pres (Age 64)
  • Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 61)
  • Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 65)
  • Mr. Robert Minowitz, Sr. VP of Global Dental Merchandising & Bus. Operations (Age 59)

Has Henry Schein been receiving favorable news coverage?

Media headlines about HSIC stock have trended somewhat positive recently, Accern reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Henry Schein earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news articles about the company an impact score of 46.57 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Henry Schein.

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of of institutional and retail investors. Top institutional investors include Longview Partners Guernsey LTD (8.99%), BlackRock Inc. (7.02%), Select Equity Group L.P. (4.35%), FMR LLC (4.33%), Janus Henderson Group PLC (2.08%) and American Century Companies Inc. (1.42%). Company insiders that own Henry Schein stock include Barry J Alperin, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Which major investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Fisher Asset Management LLC, PGGM Investments, Legal & General Group Plc, Swedbank, Meadow Creek Investment Management LLC, Northern Trust Corp and Schroder Investment Management Group. Company insiders that have sold Henry Schein company stock in the last year include Barry J Alperin, Mark E Mlotek and Paul Brons. View Insider Buying and Selling for Henry Schein.

Which major investors are buying Henry Schein stock?

HSIC stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Point72 Asset Management L.P., American Century Companies Inc., Glenmede Trust Co. NA, Janus Henderson Group PLC, Select Equity Group L.P., Canada Pension Plan Investment Board and Jane Street Group LLC. View Insider Buying and Selling for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $85.67.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $12.93 billion and generates $12.46 billion in revenue each year. The company earns $406.29 million in net income (profit) each year or $3.60 on an earnings per share basis. Henry Schein employs 22,000 workers across the globe.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]


MarketBeat Community Rating for Henry Schein (NASDAQ HSIC)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  237 (Vote Outperform)
Underperform Votes:  432 (Vote Underperform)
Total Votes:  669
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe HSIC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel